Israel Active

Israeli researchers have discovered that a common pollutant (perchlorate salts – found in pesticides and automobiles) interferes with the proper functioning of the thyroid gland, leading to hypothyroidism. They built a detection device that uses a receptor molecule to alert to pollutant’s presence.

Israel’s PainReform (see previously) has developed new improved anti-inflammatory properties for its PRF-110 pain relief treatment. These have then been successfully tested in a Phase 3 multi-site US trial of 443 patients undergoing bunionectomy surgery.

Researchers at Israel’s Sheba Medical Center have created LIV - a new generative AI-based platform offering personalized patient interactions and effective diagnostics to people with PTSD, depression, anxiety, and other mental health issues. It reduces bottlenecks from an acute shortage of mental health experts.

Researchers at Ben Gurion University and Israel’s Sheba Medical Center used AI to detect nearly 2,000 patients at high risk of developing a pulmonary embolism (lung blood clot). Sheba used the BGU algorithm to analyze the records of 46,000 patients who were admitted to ER.

Israel’s Endospan (see previously) shared good early news from the trial on 22 patients of its Nexus Aortic Arch Stent Graft System. The trial is being extended to 110 patients. 120,000+ patients suffer thoracic aortic arch disease every year in the USA and Europe.

Israel’s Discure Technologies is developing an implantable bioelectronic device designed to treat and reverse degenerative disc disease (DDD). The Discure System restores fluids and nutrients to the affected discs. DDD accounts for 35% of all lower back pain, at a cost of $100 billion in the US alone.

Tel Aviv University researchers ran an international contest to develop an algorithm to detect “Freeze of Gait” (FOG) in Parkinson’s sufferers, using data from 100 patients. The prize of $100,000 attracted nearly 25,000 solutions from AI researchers in 83 countries.

Israel’s Bettear provides Auracast-based assistive listening solutions to enhance sound experience. Its B-CASTER streamer integrates with hearing aids and cochlear implants. Other products support tour guides, teachers, entertainers, and museums.

Current and ex-students from Israel’s Technion Institute have developed CommU - a real-time language translation platform that allows doctors to converse with patients in Hebrew, English, Arabic, Russian, and most other European languages.

An Israeli clinical trial shows that diabetics who drink a beverage with the Mankai cultivated aquatic plant after meals can reduce blood sugar levels by 20%. It confirms the results of initial tests that Israel’s Ben Gurion University scientists conducted five years ago (see previously).